Thu, April 30, 2020
Wed, April 29, 2020
Tue, April 28, 2020
Mon, April 27, 2020

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $105 on, Apr 29th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-105-on-apr-29th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of SVB Leerink, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $125 to $105 on, Apr 29th, 2020.

Andrew, nor any peers, have made any analyst calls on BPMC in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources